Portnoy Law Firm Announces Class Action on Behalf of DexCom, Inc. Investors

Core Viewpoint - DexCom, Inc. is facing a class action lawsuit alleging that the company made materially false and misleading statements regarding its G6 and G7 devices, which may have health risks for users [3]. Group 1: Lawsuit Details - The class action is on behalf of investors who purchased DexCom securities between July 26, 2024, and September 17, 2025, with a deadline of December 26, 2025, for filing a lead plaintiff motion [1]. - Allegations include unauthorized design changes to the G6 and G7 devices that compromised their reliability and safety, posing health risks to users [3]. - The lawsuit claims that DexCom overstated the enhancements and reliability of the G7 devices while downplaying the severity of the issues related to the devices [3]. Group 2: Legal Representation - The Portnoy Law Firm is representing investors in this case and offers complimentary case evaluations to discuss options for recovering losses [2][4]. - The founding partner of the Portnoy Law Firm has a track record of recovering over $5.5 billion for investors affected by corporate wrongdoing [4].